We Are Hiring
FDA/CDER employment opportunities utilizing the FDA 21st Century Cures Act Hiring Authority
Are you looking for an exciting and rewarding career in the federal government?
Would you like to make a difference in how prescription drugs, including new drugs, generic drugs, biological products and biosimilars as well as over- the-counter drugs (OTC) are evaluated and approved to ensure safe and effective drugs are available to improve the health of all Americans? Look no further, join the U.S Department of Health and Human Services (HHS)/Food and Drug Administration (FDA)/Center for Drug Evaluation and Research (CDER) team!
See below list of current FDA/CDER employment opportunities utilizing the FDA 21st Century Cures Act Hiring Authority. We encourage job seekers to click the position title to view and read each job description carefully to determine if you meet the qualifications and eligibility requirements for the position(s) of interest before applying.
- Consumer Safety Officer-Special Assistant (AD-0696, Band D)
Application Period: February 14, 2023 – February 24, 2023 - Physician (AD-0602, Band C)
Application Period: February 14, 2023 – February 28, 2023 - Interdisciplinary Scientist (Telework Eligible) (AD-1320/0403/0401, Band C)
Application Period: February 13, 2023 – February 24, 2023 - Senior Policy Analyst (AD-0301, Band D)
Application Period: February 13, 2023 – February 24, 2023 - Regulatory Counsel (AD-0301, Band C and D Levels)
Application Period: February 9, 2023 – March 11, 2023 - Associate Director for Nomeclature & Labeling (AD-0601, Band E)
Application Period: February 17, 2023 – March 10, 2023 - Pharmaceutical Scientist (AD-1320/1301/0401, Band A/Band B/Band C Levels)
Application Period: February 16, 2023 – March 1, 2023
Note: United States Citizenship is required. Candidate must be a U.S. Citizen or U.S. National. Foreign nationals or legal permanent residents are not eligible for consideration. All FDA CURES employment opportunities can also be found on the FDA Title 21 job page.
For more information about FDA/CDER, visit Center for Drug Evaluation and Research.